BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119 [PMID: 28344754 DOI: 10.4239/wjd.v8.i3.112]
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/112.htm
Number Citing Articles
1
Misbah Hussain, Haq Nawaz Khan, Shahid Abbas, Ansar Ali, Muhammad Naeem Aslam, Fazli Rabbi Awan. Tetra-ARMS-PCR assay development for genotyping of AGT rs699 T/C polymorphism, its comparison with PCR-RFLP and application in a case-control association study of cardiovascular disease patientsNucleosides, Nucleotides & Nucleic Acids 2023; 42(8): 603 doi: 10.1080/15257770.2023.2181972
2
Mahmut Cerkez Ergören, Gizem Söyler, Hüseyin Sah, Eda Becer. Investigation of potential genomic biomarkers for obesity and personalized medicineInternational Journal of Biological Macromolecules 2019; 122: 493 doi: 10.1016/j.ijbiomac.2018.10.059
3
Qingzhen Liu, Shasha Lv, Jiaxi Liu, Shanshan Liu, Yinghui Wang, Gang Liu. Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathyDiabetes Research and Clinical Practice 2020; 162: 108093 doi: 10.1016/j.diabres.2020.108093
4
Magdalena Król-Kulikowska, Nikita Abramenko, Milan Jakubek, Mirosław Banasik, Marta Kepinska. The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic NephropathyJournal of Clinical Medicine 2024; 13(4): 995 doi: 10.3390/jcm13040995
5
Ling-Feng Zeng, Ying Xiao, Lin Sun. Renal Fibrosis: Mechanisms and TherapiesAdvances in Experimental Medicine and Biology 2019; 1165: 49 doi: 10.1007/978-981-13-8871-2_4
6
Jun Ling, Yan-Hua Yang. Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathyWorld Journal of Diabetes 2023; 14(9): 1412-1421 doi: 10.4239/wjd.v14.i9.1412
7
O.P. Kalra. Genetic Basis of Diabetic NephropathyAnnals of the National Academy of Medical Sciences (India) 2020; 53: 1 doi: 10.1055/s-0040-1712740
8
Neerja Aggarwal, Pawan Kumar Kare. Type 2 Diabetes - From Pathophysiology to Cyber Systems2021;  doi: 10.5772/intechopen.94642